Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis.
Tefferi A, Pardanani A, Lim KH, Abdel-Wahab O, Lasho TL, Patel J, Gangat N, Finke CM, Schwager S, Mullally A, Li CY, Hanson CA, Mesa R, Bernard O, Delhommeau F, Vainchenker W, Gilliland DG, Levine RL. Tefferi A, et al. Among authors: delhommeau f. Leukemia. 2009 May;23(5):905-11. doi: 10.1038/leu.2009.47. Epub 2009 Mar 5. Leukemia. 2009. PMID: 19262601 Free PMC article.
Molecular aspects of myeloproliferative neoplasms.
Delhommeau F, Jeziorowska D, Marzac C, Casadevall N. Delhommeau F, et al. Int J Hematol. 2010 Mar;91(2):165-73. doi: 10.1007/s12185-010-0530-z. Epub 2010 Feb 27. Int J Hematol. 2010. PMID: 20186505 Review.
New mutations and pathogenesis of myeloproliferative neoplasms.
Vainchenker W, Delhommeau F, Constantinescu SN, Bernard OA. Vainchenker W, et al. Among authors: delhommeau f. Blood. 2011 Aug 18;118(7):1723-35. doi: 10.1182/blood-2011-02-292102. Epub 2011 Jun 7. Blood. 2011. PMID: 21653328 Free article. Review.
Role of TET2 mutations in myeloproliferative neoplasms.
Pronier E, Delhommeau F. Pronier E, et al. Among authors: delhommeau f. Curr Hematol Malig Rep. 2012 Mar;7(1):57-64. doi: 10.1007/s11899-011-0108-8. Curr Hematol Malig Rep. 2012. PMID: 22200996
Somatic genetic alterations predict hematological progression in GATA2 deficiency.
Largeaud L, Collin M, Monselet N, Vergez F, Fregona V, Larcher L, Hirsch P, Duployez N, Bidet A, Luquet I, Bustamante J, Dufrechou S, Prade N, Nolla M, Hamelle C, Tavitian S, Habib C, Meynier M, Bellanne-Chantelot C, Donadieu J, De Fontbrune FS, Fieschi C, Ferster A, Delhommeau F, Delabesse E, Pasquet M. Largeaud L, et al. Among authors: delhommeau f. Haematologica. 2023 Jun 1;108(6):1515-1529. doi: 10.3324/haematol.2022.282250. Haematologica. 2023. PMID: 36727400 Free PMC article.
Oncogenic mechanisms in myeloproliferative disorders.
Delhommeau F, Pisani DF, James C, Casadevall N, Constantinescu S, Vainchenker W. Delhommeau F, et al. Cell Mol Life Sci. 2006 Dec;63(24):2939-53. doi: 10.1007/s00018-006-6272-7. Cell Mol Life Sci. 2006. PMID: 17131059 Free PMC article. Review.
The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity.
James C, Mazurier F, Dupont S, Chaligne R, Lamrissi-Garcia I, Tulliez M, Lippert E, Mahon FX, Pasquet JM, Etienne G, Delhommeau F, Giraudier S, Vainchenker W, de Verneuil H. James C, et al. Among authors: delhommeau f. Blood. 2008 Sep 15;112(6):2429-38. doi: 10.1182/blood-2008-02-137877. Epub 2008 Jul 8. Blood. 2008. PMID: 18612101 Free article.
91 results